Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | histone deacetylase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.041 | 1 | 1 |
Trypanosoma cruzi | histone deacetylase 1, putative | 0.0077 | 0 | 0.5 |
Toxoplasma gondii | histone deacetylase HDAC3 | 0.0077 | 0 | 0.5 |
Toxoplasma gondii | histone deacetylase HDAC2 | 0.0077 | 0 | 0.5 |
Plasmodium falciparum | histone deacetylase 1 | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Trypanosoma cruzi | histone deacetylase 1, putative | 0.0077 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.041 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0077 | 0 | 0.5 |
Entamoeba histolytica | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Trypanosoma brucei | histone deacetylase 1 | 0.0077 | 0 | 0.5 |
Leishmania major | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0077 | 0 | 0.5 |
Giardia lamblia | Histone deacetylase | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.041 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Plasmodium vivax | histone deacetylase 1, putative | 0.0077 | 0 | 0.5 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.041 | 1 | 1 |
Leishmania major | histone deacetylase, putative | 0.0077 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 19 nM | BindingDB_Patents: Flag Assay. Novel compounds were tested for their ability to inhibit histone deacetylase, subtype 1 (HDAC1) using an in vitro deacetylation assay. The enzyme source for this assay was an epitope-tagged human HDAC1 complex immuno-purified from stably expressing mammalian cells. The substrate consisted of a commercial product containing an acetylated lysine side chain (BIOMOL Research Laboratories, Inc., Plymouth Meeting, Pa.). Upon deacetylation of the substrate by incubation with the purified HDAC1 complex, a fluorophore is produced that is directly proportional to the level of deacetylation. Using a substrate concentration at the Km for the enzyme preparation, the deacetylation assay was performed in the presence of increasing concentrations of novel compounds to semi-quantitatively determine the concentration of compound required for 50% inhibition (IC50) of the deacetylation reaction. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.